These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35178443)

  • 1. Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53.
    Wang WL; Batzorig U; Hung CS; Wei PL; Huang CY; Chang YJ
    Biomed Res Int; 2022; 2022():1322788. PubMed ID: 35178443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach.
    Cheraghi-Shavi T; Jalal R; Minuchehr Z
    PLoS One; 2023; 18(8):e0289535. PubMed ID: 37535601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico analysis to identify miR-1271-5p/PLCB4 (phospholipase C Beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancer.
    Lee CC; Lee AW; Wei PL; Liu YS; Chang YJ; Huang CY
    Sci Rep; 2023 Mar; 13(1):4366. PubMed ID: 36927770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis.
    Ohashi T; Idogawa M; Sasaki Y; Suzuki H; Tokino T
    Mol Cancer Res; 2013 Dec; 11(12):1554-63. PubMed ID: 24140838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Novel miRNAs, Targeting Genes, Signaling Pathway, and the Small Molecule for Overcoming Oxaliplatin Resistance of Metastatic Colorectal Cancer.
    Misbah M; Kumar M; Lee KH; Shen SC
    Biomed Res Int; 2022; 2022():3825760. PubMed ID: 36193307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
    Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
    Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.
    Chen J; Wang Z; Shen X; Cui X; Guo Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
    Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key genes in colorectal cancer using random walk with restart.
    Cui X; Shen K; Xie Z; Liu T; Zhang H
    Mol Med Rep; 2017 Feb; 15(2):867-872. PubMed ID: 28000901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.
    Makondi PT; Lee CH; Huang CY; Chu CM; Chang YJ; Wei PL
    PLoS One; 2018; 13(1):e0189582. PubMed ID: 29342159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer.
    Taskoparan B; Seza EG; Demirkol S; Tuncer S; Stefek M; Gure AO; Banerjee S
    Cell Oncol (Dordr); 2017 Dec; 40(6):563-578. PubMed ID: 28929377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning.
    Hammad A; Elshaer M; Tang X
    Math Biosci Eng; 2021 Oct; 18(6):8997-9015. PubMed ID: 34814332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer.
    Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R
    Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis of RNA-binding proteins in human colorectal cancer.
    Fan X; Liu L; Shi Y; Guo F; Wang H; Zhao X; Zhong D; Li G
    World J Surg Oncol; 2020 Aug; 18(1):222. PubMed ID: 32828126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
    Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
    Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification of a common different gene expression signature in patients with colorectal cancer.
    Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
    Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis.
    Li J; Wang Y; Wang X; Yang Q
    World J Surg Oncol; 2020 Mar; 18(1):50. PubMed ID: 32127012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Sitosterol Reverses Multidrug Resistance via BCRP Suppression by Inhibiting the p53-MDM2 Interaction in Colorectal Cancer.
    Wang Z; Zhan Y; Xu J; Wang Y; Sun M; Chen J; Liang T; Wu L; Xu K
    J Agric Food Chem; 2020 Mar; 68(12):3850-3858. PubMed ID: 32167760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of hub genes and pathways in colorectal cancer with microarray technology.
    Wang Y; Zheng T
    Pathol Oncol Res; 2014 Jul; 20(3):611-8. PubMed ID: 24504536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.